Melmed S (2006) Acromegaly. N Engl J Med 355:2558–2573. https://doi.org/10.1056/NEJMra062453

Article  CAS  PubMed  Google Scholar 

Kasuki L, Rocha PdaS, Lamback EB, Gadelha MR (2020) Determinants of morbidities and mortality in acromegaly. Arch Endocrinol Metab 63:630–637. https://doi.org/10.20945/2359-3997000000193

Article  Google Scholar 

Maione L, Chanson P (2019) National acromegaly registries. Best Pract Res Clin Endocrinol Metab 33:101264. https://doi.org/10.1016/j.beem.2019.02.001

Article  PubMed  Google Scholar 

Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of Acromegaly and the impact of the Current Treatment Landscape: an update. Endocr Rev 40:268–332. https://doi.org/10.1210/er.2018-00115

Article  PubMed  Google Scholar 

Baralle FE, Giudice J (2017) Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol 18:437–451. https://doi.org/10.1038/nrm.2017.27

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang ET, Sandberg R, Luo S et al (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470–476. https://doi.org/10.1038/nature07509

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong X, Chen R (2020) Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy. Oncogene 39:2231–2242. https://doi.org/10.1038/s41388-019-1138-2

Article  CAS  PubMed  Google Scholar 

Venables JP (2004) Aberrant and alternative splicing in Cancer. Cancer Res 64:7647–7654. https://doi.org/10.1158/0008-5472.CAN-04-1910

Article  CAS  PubMed  Google Scholar 

Rymond B (2007) Targeting the spliceosome. Nat Chem Biol 3:533–535. https://doi.org/10.1038/nchembio0907-533

Article  CAS  PubMed  Google Scholar 

Kotake Y, Sagane K, Owa T et al (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol 3:570–575. https://doi.org/10.1038/nchembio.2007.16

Article  CAS  PubMed  Google Scholar 

Vázquez-Borrego MC, Fuentes-Fayos AC, Venegas-Moreno E et al (2019) Splicing Machinery is dysregulated in Pituitary neuroendocrine tumors and is Associated with aggressiveness features. Cancers 11:1439. https://doi.org/10.3390/cancers11101439

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pastorino L, Grillo F, Albertelli M et al (2021) Insights into mechanisms of Tumorigenesis in Neuroendocrine neoplasms. Int J Mol Sci 22:10328. https://doi.org/10.3390/ijms221910328

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of Pituitary tumors. Endocr Pathol 33:6–26. https://doi.org/10.1007/s12022-022-09703-7

Article  CAS  PubMed  Google Scholar 

Kim J, Hwang Y, Park YW et al (2022) Revisiting growth hormone nadir cut-offs for remission in patients with acromegaly. Eur J Endocrinol 186:657–665. https://doi.org/10.1530/EJE-21-1094

Article  CAS  PubMed  Google Scholar 

Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617 discussion 617–618. https://doi.org/10.1227/00006123-199310000-00008

Article  CAS  PubMed  Google Scholar 

Abboud D, Daly AF, Dupuis N et al (2020) GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11. Nat Commun 11:4752. https://doi.org/10.1038/s41467-020-18500-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ritvonen E, Pitkänen E, Karppinen A et al (2017) Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas. Eur J Endocrinol 176:243–252. https://doi.org/10.1530/EJE-16-0620

Article  CAS  PubMed  Google Scholar 

Ronchi CL, Peverelli E, Herterich S et al (2016) Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur J Endocrinol 174:363–372. https://doi.org/10.1530/EJE-15-1064

Article  CAS  PubMed  Google Scholar 

Ben-Shlomo A, Deng N, Ding E et al (2020) DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas. J Clin Invest 130:5738–5755. https://doi.org/10.1172/JCI138540

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hage M, Viengchareun S, Brunet E et al (2018) Genomic alterations and Complex Subclonal Architecture in sporadic GH-Secreting pituitary adenomas. J Clin Endocrinol Metab 103:1929–1939. https://doi.org/10.1210/jc.2017-02287

Article  PubMed  Google Scholar 

Lekva T, Berg JP, Lyle R et al (2013) Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas. Endocrinology 154:3331–3343. https://doi.org/10.1210/en.2013-1051

Article  CAS  PubMed  Google Scholar 

Makarov EM, Makarova OV, Urlaub H et al (2002) Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science 298:2205–2208. https://doi.org/10.1126/science.1077783

Article  CAS  PubMed  Google Scholar 

Lin K-T, Lu R-M, Tarn W-Y (2004) The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo. Mol Cell Biol 24:9176–9185. https://doi.org/10.1128/MCB.24.20.9176-9185.2004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arango M, Holbert S, Zala D et al (2006) CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J Neurosci off J Soc Neurosci 26:4649–4659. https://doi.org/10.1523/JNEUROSCI.5409-05.2006

Article  CAS  Google Scholar 

Andresen JM, Gayán J, Cherny SS et al (2007) Replication of twelve association studies for Huntington’s disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44–50. https://doi.org/10.1136/jmg.2006.045153

Article  CAS  PubMed  Google Scholar 

Montes M, Coiras M, Becerra S et al (2015) Functional consequences for apoptosis by transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing. PLoS ONE 10:e0139812. https://doi.org/10.1371/journal.pone.0139812

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montes M, Cloutier A, Sánchez-Hernández N et al (2012) TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription. Mol Cell Biol 32:751–762. https://doi.org/10.1128/MCB.06255-11

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore MJ, Wang Q, Kennedy CJ, Silver PA (2010) An alternative splicing network links cell-cycle control to apoptosis. Cell 142:625–636. https://doi.org/10.1016/j.cell.2010.07.019

Article  CAS  PubMed  PubMed Central